These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. [In vitro effect of bacterial extracts of S. aureus in chemokinesis and chemotaxis of polymorphonuclear cells]. Cisneros González N; Martínez-Cairo Cueto S; Santos Preciado JI Rev Alerg Mex; 1995; 42(1):9-13. PubMed ID: 7735864 [TBL] [Abstract][Full Text] [Related]
26. [Duration of incubation in Boyden-type chambers in evaluation of the number of chemotactic polymorphonuclear leukocytes]. Lobashevskiĭ AL Lab Delo; 1983; (7):55-6. PubMed ID: 6194360 [No Abstract] [Full Text] [Related]
27. Fucose-binding Lotus tetragonolobus lectin binds to human polymorphonuclear leukocytes and induces a chemotactic response. VanEpps DE; Tung KS J Immunol; 1977 Sep; 119(3):1187-9. PubMed ID: 330752 [TBL] [Abstract][Full Text] [Related]
28. Chemotaxis and random migration of polymorphonuclear leukocytes in ulcerative colitis examined by the agarose method. Hermanowicz A; Nawarska Z Scand J Gastroenterol; 1981; 16(8):961-6. PubMed ID: 7336136 [TBL] [Abstract][Full Text] [Related]
31. Localization of chemotactic activity and 64 kD protein phosphorylation for human polymorphonuclear leukocytes in N-terminus of the chemotactic protein LUCT/IL-8. Suzuki K; Koshio O; Ishida-Okawara A; Shibata M; Yamakawa Y; Tagawa M; Ota H; Kuramoto A; Mizuno S Biochem Biophys Res Commun; 1989 Sep; 163(3):1298-305. PubMed ID: 2675839 [TBL] [Abstract][Full Text] [Related]
32. Effect of Bacteroides fragilis cellular components on chemotactic activity of polymorphonuclear leukocytes towards Escherichia coli. Namavar F; Verweij-Van Vught AM; Bal M; MacLaren DM J Med Microbiol; 1987 Sep; 24(2):119-24. PubMed ID: 3309320 [TBL] [Abstract][Full Text] [Related]
33. Bilirubin inhibits the chemotactic activity of human polymorphonuclear leukocytes in vitro. Miler I; Vondrácek J; Hromádková L Folia Microbiol (Praha); 1981; 26(5):413-6. PubMed ID: 7033084 [No Abstract] [Full Text] [Related]
34. Investigation of the PMN chemotaxis in periodontal disease. Zafiropoulos GG; Flores-de-Jacoby L; Wirth J; Nisengard RJ; Havemann K; Kolb G Dtsch Zahn Mund Kieferheilkd Zentralbl; 1991; 79(1):15-22. PubMed ID: 9239950 [TBL] [Abstract][Full Text] [Related]
35. Impaired chemotactic responses of bronchoalveolar leukocytes in experimental pneumoconiosis. Donaldson K; Brown GM; Brown DM; Slight J; Robertson MD; Davis JM J Pathol; 1990 Jan; 160(1):63-9. PubMed ID: 2156037 [TBL] [Abstract][Full Text] [Related]
38. Chemotactic factors as cause of polyleukocyte urine in urinary tract infection: chemotactic activity of urinary protein fraction. Tsujimura S; Otaguro K; Sasaki M; Tanaka R Invest Urol; 1980 Jan; 17(4):269-72. PubMed ID: 7351359 [TBL] [Abstract][Full Text] [Related]
39. In vivo potentiation of polymorphonuclear leukocyte chemotaxis by clindamycin. Skoutelis AT; Lianou PE; Bassaris HP Infection; 1993; 21(5):321-3. PubMed ID: 8300250 [TBL] [Abstract][Full Text] [Related]
40. The ionic basis of chemotaxis. Separate cation requirements for neutrophil orientation and locomotion in a gradient of chemotactic peptide. Marasco WA; Becker EL; Oliver JM Am J Pathol; 1980 Mar; 98(3):749-68. PubMed ID: 6767408 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]